Icu Medical annual gross margin
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Icu Medical's gross margin was 36.84% for fiscal 2025.
View full Icu Medical company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 36.84% | +2.22 pp |
| 2024 | 2024-12-31 | 34.62% | +1.87 pp |
| 2023 | 2023-12-31 | 32.75% | +2.15 pp |
| 2022 | 2022-12-31 | 30.60% | −6.73 pp |
| 2021 | 2021-12-31 | 37.34% | +1.03 pp |
| 2020 | 2020-12-31 | 36.31% | −0.96 pp |
| 2019 | 2019-12-31 | 37.27% | −3.45 pp |
| 2018 | 2018-12-31 | 40.72% | +7.75 pp |
| 2017 | 2017-12-31 | 32.96% | −20.12 pp |
| 2016 | 2016-12-31 | 53.09% | +0.17 pp |
| 2015 | 2015-12-31 | 52.92% | +3.96 pp |
| 2014 | 2014-12-31 | 48.96% | −0.37 pp |
| 2013 | 2013-12-31 | 49.32% | −0.07 pp |
| 2012 | 2012-12-31 | 49.39% | +2.29 pp |
| 2011 | 2011-12-31 | 47.11% | +1.53 pp |
| 2010 | 2010-12-31 | 45.58% | −0.84 pp |
| 2009 | 2009-12-31 | 46.41% | +2.54 pp |
| 2008 | 2008-12-31 | 43.87% | +2.28 pp |
| 2007 | 2007-12-31 | 41.59% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 42.61% | +4.70 pp |
| Q1 2026 | 2026-03-31 | 38.89% | +4.15 pp |
| Q4 2025 | 2025-12-31 | 37.54% | +1.46 pp |
| Q3 2025 | 2025-09-30 | 37.41% | +2.64 pp |
| Q2 2025 | 2025-06-30 | 37.91% | +3.13 pp |
| Q1 2025 | 2025-03-31 | 34.75% | +2.06 pp |
| Q4 2024 | 2024-12-31 | 36.08% | +6.90 pp |
| Q3 2024 | 2024-09-30 | 34.77% | +1.53 pp |
| Q2 2024 | 2024-06-30 | 34.78% | −0.24 pp |
| Q1 2024 | 2024-03-31 | 32.69% | −1.08 pp |
| Q4 2023 | 2023-12-31 | 29.19% | −1.08 pp |
| Q3 2023 | 2023-09-30 | 33.24% | +2.06 pp |
| Q2 2023 | 2023-06-30 | 35.01% | +5.14 pp |
| Q1 2023 | 2023-03-31 | 33.77% | +2.69 pp |
| Q4 2022 | 2022-12-31 | 30.27% | −7.17 pp |
| Q3 2022 | 2022-09-30 | 31.18% | −6.85 pp |
| Q2 2022 | 2022-06-30 | 29.87% | −8.53 pp |
| Q1 2022 | 2022-03-31 | 31.08% | −4.34 pp |
| Q4 2021 | 2021-12-31 | 37.44% | +0.03 pp |
| Q3 2021 | 2021-09-30 | 38.03% | +2.26 pp |
| Q2 2021 | 2021-06-30 | 38.40% | +3.37 pp |
| Q1 2021 | 2021-03-31 | 35.43% | −1.52 pp |
| Q4 2020 | 2020-12-31 | 37.41% | +1.23 pp |
| Q3 2020 | 2020-09-30 | 35.76% | −2.80 pp |
| Q2 2020 | 2020-06-30 | 35.03% | +1.77 pp |
| Q1 2020 | 2020-03-31 | 36.95% | −3.94 pp |
| Q4 2019 | 2019-12-31 | 36.17% | −3.38 pp |
| Q3 2019 | 2019-09-30 | 38.56% | −2.58 pp |
| Q2 2019 | 2019-06-30 | 33.26% | −8.85 pp |
| Q1 2019 | 2019-03-31 | 40.89% | +0.83 pp |
| Q4 2018 | 2018-12-31 | 39.56% | +2.41 pp |
| Q3 2018 | 2018-09-30 | 41.14% | +8.62 pp |
| Q2 2018 | 2018-06-30 | 42.11% | +15.55 pp |
| Q1 2018 | 2018-03-31 | 40.05% | +4.15 pp |
| Q4 2017 | 2017-12-31 | 37.15% | −15.90 pp |
| Q3 2017 | 2017-09-30 | 32.51% | −20.29 pp |
| Q2 2017 | 2017-06-30 | 26.56% | −25.27 pp |
| Q1 2017 | 2017-03-31 | 35.90% | −18.89 pp |
| Q4 2016 | 2016-12-31 | 53.05% | −0.34 pp |
| Q3 2016 | 2016-09-30 | 52.80% | −0.99 pp |
| Q2 2016 | 2016-06-30 | 51.83% | −0.40 pp |
| Q1 2016 | 2016-03-31 | 54.79% | +2.62 pp |
| Q4 2015 | 2015-12-31 | 53.39% | +3.72 pp |
| Q3 2015 | 2015-09-30 | 53.79% | +4.54 pp |
| Q2 2015 | 2015-06-30 | 52.23% | +4.52 pp |
| Q1 2015 | 2015-03-31 | 52.17% | +2.98 pp |
| Q4 2014 | 2014-12-31 | 49.67% | −0.30 pp |
| Q3 2014 | 2014-09-30 | 49.25% | −0.20 pp |
| Q2 2014 | 2014-06-30 | 47.72% | −0.64 pp |
| Q1 2014 | 2014-03-31 | 49.20% | −0.32 pp |
| Q4 2013 | 2013-12-31 | 49.97% | −0.56 pp |
| Q3 2013 | 2013-09-30 | 49.45% | −0.54 pp |
| Q2 2013 | 2013-06-30 | 48.36% | −2.21 pp |
| Q1 2013 | 2013-03-31 | 49.52% | +3.22 pp |
| Q4 2012 | 2012-12-31 | 50.52% | +3.51 pp |
| Q3 2012 | 2012-09-30 | 49.99% | +3.46 pp |
| Q2 2012 | 2012-06-30 | 50.57% | +4.04 pp |
| Q1 2012 | 2012-03-31 | 46.30% | −2.14 pp |
| Q4 2011 | 2011-12-31 | 47.02% | −1.48 pp |
| Q3 2011 | 2011-09-30 | 46.53% | +1.59 pp |
| Q2 2011 | 2011-06-30 | 46.53% | −0.12 pp |
| Q1 2011 | 2011-03-31 | 48.45% | +6.61 pp |
| Q4 2010 | 2010-12-31 | 48.49% | +5.58 pp |
| Q3 2010 | 2010-09-30 | 44.93% | −1.48 pp |
| Q2 2010 | 2010-06-30 | 46.65% | −1.64 pp |
| Q1 2010 | 2010-03-31 | 41.84% | −7.06 pp |
| Q4 2009 | 2009-12-31 | 42.92% | −3.42 pp |
| Q3 2009 | 2009-09-30 | 46.42% | +0.84 pp |
| Q2 2009 | 2009-06-30 | 48.29% | +5.48 pp |
| Q1 2009 | 2009-03-31 | 48.89% | +9.10 pp |
| Q4 2008 | 2008-12-31 | 46.34% | — |
| Q3 2008 | 2008-09-30 | 45.58% | — |
| Q2 2008 | 2008-06-30 | 42.81% | — |
| Q1 2008 | 2008-03-31 | 39.80% | — |
Over the last five reported fiscal years, Icu Medical's gross margin increased from 36.31% to 36.84%, a change of +0.53 percentage points. The latest reported quarter, Q2 2026, shows 42.61%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Icu Medical filings at SEC.gov ↗